Announcements

Director Nancy Thornberry filed a Form 4 with the SEC on September 4, 2026, reporting two sales of Denali Therapeutics Inc. (NASDAQ:DNLI) common stock executed on September 2, 2026, under a pre-established Rule 10b5-1 trading plan.

Director Kevin Omar Meyers filed a Form 4 with the SEC on September 4, 2026, reporting the acquisition of restricted stock units in Hornbeck Offshore Services, Inc., with the transaction dated September 2, 2026.

Pinnacle West Capital Corporation and Arizona Public Service Company jointly filed a Form 8-K on September 4, 2026, disclosing that Pinnacle West will participate in meetings with securities analysts and investors in September 2026 and will use handouts attached as Exhibit 99.1.

Arrow Electronics, Inc. filed an 8-K on September 4, 2026, disclosing that on September 2, 2026, the company entered into Amendment No. 36 to its North American Asset Securitization Facility, extending its maturity and increasing its limit.

Ategrity Specialty Insurance Company Holdings filed a Form 8-K on September 4, 2026, disclosing a third amendment and restatement of its employment agreement with President and Chief Underwriting Officer Chris Schenk.

Corvex, Inc. (NASDAQ:MOVE) filed a Form 8-K on September 4, 2026 disclosing unaudited pro forma condensed combined financial statements reflecting its completed acquisition of Corvex Legacy Holdings, Inc., formerly named Corvex, Inc.

BorgWarner Inc. filed a current report on September 4, 2026, under Item 7.01 Regulation FD Disclosure, reiterating its prior statements on turbine generator production expectations at its Hendersonville, North Carolina facility.